This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Time to update Drug Channels' exclusive look at independentpharmacy owners’ business economics. Our analysis again reveals that despite what you may have heard, many independentpharmacies continue to hang on in a highly challenging retail environment.
Last week , I highlighted the largest pharmacy chains that will participate in the 2021 Medicare Part D prescription drug plans (PDP). The Centers for Medicare & Medicaid Services (CMS) continues to take a hands-off approach to pharmacy networks. Details and a handy scorecard below. d/b/a Drug Channels Institute.
As predicted last year, Walgreens’ specialty pharmacy business has collapsed, which led to a slightly less concentrated industry. Read on for additional observations about hospitals, independentpharmacies, the dynamics that created this market structure, and why life in plastic is fantastic. d/b/a Drug Channels Institute.
What's more, plans from Aetna, Humana, WellCare, and UnitedHealthcare will not have any independentpharmacies participating via PSAOs as preferred pharmacies. As you will see below, the largest PSAOs will move further away from preferred networks in 2023.
Recent posts have covered: Walgreens’ new direction; controversary over independentpharmacy counting; insurer consolidation; retail pharmacy M&A; drug pricing policy; Prime Therapeutics; 340B contract pharmacy litigation; pharmaceutical antitrust; oncology care model; and Peter Bach’s nuptials.
Plans from Aetna, Humana, WellCare, and UnitedHealthcare will not have any independentpharmacies participating via PSAOs as preferred pharmacies. Smaller pharmacies' ability to navigate away provides more bad news for stand-alone Part D market—and another unexpected consequence of the Inflation Reduction Act of 2022.
Time to update Drug Channels' exclusive look at independentpharmacy owners’ business economics. Our analysis reveals that despite what you may have heard, many independentpharmacies have figured out how to survive a highly challenging environment.
In upcoming articles, I’ll examine how chain and independentpharmacies will participate in these plans and what that means for pharmacy profits. Below, I provide historical data on preferred networks’ growth and then discuss the top nine companies offering the 2021 plans. d/b/a Drug Channels Institute.
In upcoming articles, I’ll delve into chain and independentpharmacies’ participation in the major 2024 preferred networks. Below, I provide historical data on preferred networks’ growth and update the seven top companies’ 2024 offerings. The 2024 data provide early evidence of a shrinking PDP market.
“In Rutledge , the Court shined a light on one abusive practice – PBMs’ use of secret, arbitrary ‘MAC lists’ (maximum allowable costs) that PBMs use to pay pharmacies – a practice that can force pharmacies to accept payments below the pharmacies’ actual costs of the drugs they dispense.
The Royal Pharmaceutical Society (RPS) says other independentpharmacies have also had to slow down the rate of vaccination. Robbie Turner, RPS Director of Pharmacy, said: “This year many more people are anticipating receiving a flu vaccination and they need assurance that sufficient stocks are available.
Key players, including drug manufacturers, independentpharmacies, and physicians, find themselves navigating an intricate web of issues, and the repercussions ultimately impact the most vulnerable stakeholders: patients. Unpacking Concerns in the PBM Landscape: The Catalysts The PBM landscape is rife with tension.
Medicure Enters the US Online Pharmacy World with Acquisition of Marley Drug , PR Newswire. Dave Marley has just sold Marley Drug, the independentpharmacy he founded in 2003, to Medicure Pharma. Sometimes, the little guy wins big. Marley Drug generated $1.7 million in profits on revenues of $7.0
Plans from Humana, WellCare, and UnitedHealthcare will again not have any independentpharmacies participating via PSAOs as preferred pharmacies. Looks like the presence of smaller pharmacies in preferred networks will not be far behind. Thanks to the Inflation Reduction Act (IRA), the PDP market is vanishing.
Wishing you and your family health and happiness, Adam and the DCI team In this issue: Unexplainable pharmacy reimbursements in Medicare Part D Surprise!
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content